OQROGet OQRO Pro
Insider trade

Jazz Pharmaceuticals (JAZZ)Director bought ~$1.9M

Seamus Mulligan, Director at Jazz Pharmaceuticals, bought ~$1.9M of Jazz Pharmaceuticals shares.

~$1.9M
Approx. value · 19K sh @ $98.91
100K
Holds after · shares reported
Traded
May 9, 2025
Filed
May 13, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 10, 2025Insider · 2 peopleInsiders: 2 sales (~$490K)
  2. Apr 1, 2025InsiderCEO sold ~$186K of JAZZ shares in the open market
  3. May 1, 2025InsiderCEO sold ~$116K of JAZZ shares in the open market
  4. May 2, 2025InsiderCEO sold ~$60K of JAZZ shares in the open market
  5. May 9, 2025 · this disclosureInsiderDirector purchased ~$1.9M of JAZZ shares in the open market

What came next

  1. May 9, 2025Insider · 1 personInsiders: 2 purchases (~$7.9M)
  2. May 12, 2025InsiderDirector purchased ~$167K of JAZZ shares in the open market
  3. Jun 2, 2025InsiderCEO sold ~$54K of JAZZ shares in the open market
  4. Jun 3, 2025InsiderCEO sold ~$55K of JAZZ shares in the open market
  5. Jul 1, 2025Insider · 1 personInsiders: 2 sales (~$108K)
  6. Aug 1, 2025InsiderCEO sold ~$113K of JAZZ shares in the open market
  7. Sep 2, 2025Insider · 1 personInsiders: 2 sales (~$772K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Jazz Pharmaceuticals

For Jazz Pharmaceuticals, OQRO holds 14 insider filings (SEC Form 4 or Form 144) and 10 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JAZZ page.

Other recent filings by Seamus Mulligan, Director

The full history of Seamus Mulligan, Director is on the profile page.

How this filing works

Other disclosures at Jazz Pharmaceuticals

Everything OQRO holds on this company is on its JAZZ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data